179 related articles for article (PubMed ID: 29773689)
1. Risk factors for lung disease progression in children with cystic fibrosis.
van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
[TBL] [Abstract][Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
Sequeiros IM; Jarad N
Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
[TBL] [Abstract][Full Text] [Related]
6. Effect of allergic bronchopulmonary aspergillosis on FEV
Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A
Arch Dis Child; 2017 Aug; 102(8):742-747. PubMed ID: 28325727
[TBL] [Abstract][Full Text] [Related]
7. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
8. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
12. Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.
van Horck M; Winkens B; Wesseling G; van Vliet D; van de Kant K; Vaassen S; de Winter-de Groot K; de Vreede I; Jöbsis Q; Dompeling E
Sci Rep; 2017 Sep; 7(1):12350. PubMed ID: 28955051
[TBL] [Abstract][Full Text] [Related]
13. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
De Baets F; De Keyzer L; Van Daele S; Schelstraete P; Van Biervliet S; Van Braeckel E; Thomas M; Wanyama SS
Pediatr Allergy Immunol; 2018 Nov; 29(7):726-731. PubMed ID: 29981532
[TBL] [Abstract][Full Text] [Related]
15. Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience.
Briggs EC; Nguyen T; Wall MA; MacDonald KD
Clin Respir J; 2012 Jan; 6(1):56-64. PubMed ID: 21595857
[TBL] [Abstract][Full Text] [Related]
16. A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.
Sawicki GS; Ayyagari R; Zhang J; Signorovitch JE; Fan L; Swallow E; Latremouille-Viau D; Wu EQ; Shi L
Pediatr Pulmonol; 2013 Oct; 48(10):954-61. PubMed ID: 23255309
[TBL] [Abstract][Full Text] [Related]
17. Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis.
Cousin M; Molinari N; Foulongne V; Caimmi D; Vachier I; Abely M; Chiron R
Influenza Other Respir Viruses; 2016 Mar; 10(2):109-12. PubMed ID: 26493783
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH
Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845
[TBL] [Abstract][Full Text] [Related]
19. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
[TBL] [Abstract][Full Text] [Related]
20. The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort.
Kröner C; Kappler M; Grimmelt AC; Laniado G; Würstl B; Griese M
BMC Pulm Med; 2013 Nov; 13():61. PubMed ID: 24180379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
